Search results

42 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC-led HIV Study Named as One of the Discoveries of the Decade
National Geographic selected the multinational HPTN 052 HIV trial, led by Myron Cohen, MD, as one of the discoveries of the decade.
Located in Vital Signs / 2019 / Dec. 12
NC, SC Join Forces to Combat HIV Epidemic
The “Carolinas United to End HIV (CUE-HIV)” partnership aims to decrease the number of HIV infections by 90 percent in ten years.
Located in Biochemistry and Biophysics News / / 2019 / July
UNC Awarded $19.4 million to Continue National Effort to Combat HIV Comorbidities
The Multicenter AIDS Cohort Study / Women’s Interagency HIV Study Combined Cohort Study is a collaborative research effort to understand and reduce the impact of chronic health conditions that affect people living with HIV. Adaora Adimora, MD, MPH, leads the UNC-Chapel Hill site, one of 13 across the country.
Located in Biochemistry and Biophysics News / / 2019 / October
Adimora Elected to National Academy of Medicine
Adaora Adimora, MD, MPH, in the department of medicine, was selected for this honor for her integral work in the field of HIV prevention.
Located in Biochemistry and Biophysics News / / 2019 / October
UNC Hosts World AIDS Day Event, CFAR Symposium
Friday December 6, the Institute for Global Health and Infectious Diseases and Center for AIDS Research will host event special event at the Bioinformatics Building. Elsevier Press recently reviewed the impact of institutions in HIV research worldwide, and UNC-Chapel Hill ranked fourth.
Located in Biochemistry and Biophysics News / / 2019 / December
T cells alone are sufficient to establish and maintain HIV infection in the brain
Led by J. Victor Garcia, PhD, UNC researchers report in the Journal of Clinical Investigation that T cells in the brain may be an important HIV reservoir that should be targeted by HIV cure approaches.
Located in Biochemistry and Biophysics News / / 2018 / June
Long-acting injectable implant shows promise for HIV treatment and prevention
The long-acting antiretroviral drug formulation, developed by UNC School of Medicine researchers Rahima Benhabbour, PhD and Martina Kovarova, PhD, is injected under the skin and forms into a solid implant that dissolves slowly to release anti-HIV medication over time.
Located in Biochemistry and Biophysics News / / 2018 / October
Eron, Kuhlman named Smithies Investigators
The UNC School of Medicine selected professors from the departments of medicine and biochemistry & biophysics for the annual award in honor of the late Oliver Smithies, UNC’s first Nobel Prize winner.
Located in Biochemistry and Biophysics News / / 2018 / December
UNC Study Advances the Ability to Expose Latent HIV
UNC researchers led by Nancie Archin, PhD, and David Margolis, MD, have shown that interval dosing of the drug Vorinostat reverses HIV latency and is well-tolerated in people living with HIV. However, while Vorinostat makes latent HIV easier to detect, it does not clear or deplete infection, meaning additional advances will be needed to achieve a cure. These results were published in the Journal of Clinical Investigation on July 17.
Located in Biochemistry and Biophysics News / / 2017 / July
The Hunt for a Cure to HIV
In recognition of World AIDS Day on Dec. 1, UNC Health Care and our friends at StoryDrivenMedia created this video featuring HIV Cure Center researchers David Margolis, MD, and Nancie Archin, PhD, as well as clinical trial participant Rob Hill.
Located in Biochemistry and Biophysics News / / 2017 / November